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Abstract STAM/EAST/Hbp family of proteins consists of
eight members well conserved from yeast to mammals. The
basic domain architecture is comprised of an N-terminal Vps27,
Hrs and STAM homology domain, a ubiquitin-interacting motif
and a central Src homology-3 domain. Vertebrate members also
carry an immunoreceptor tyrosine-based activation motif.
STAM/EAST/Hbp proteins become tyrosine-phosphorylated by
a variety of cytokines and growth factors. STAM 1 and STAM
2A are involved in cytokine-mediated signalling for DNA
synthesis and c-myc induction. EAST and STAM 2A/Hbp play
a role in receptor-mediated endo- and exocytosis and probably
also in the regulation of actin cytoskeleton. Knockout experi-
ments implicate a role for STAM 1 in neural cell survival. A
picture is emerging of STAM/EAST/Hbp proteins acting as
integrators of thus far mechanistically disparate cellular signal-
ling events. ß 2001 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
Key words: Adapter; EAST; Endocytosis; Hbp; Receptor;
STAM
1. Introduction
STAM (signal-transducing adapter molecule) and EAST
(EGFR-associated protein with SH3 and TAM domains)
were originally discovered as tyrosine-phosphorylatable pro-
teins involved in interleukin-2 (IL-2) and epidermal growth
factor (EGF) receptor signalling, respectively [1,2]. Hbp
(Hrs-binding protein) was identi¢ed based on its binding to
Hrs, a hepatocyte growth factor-regulated tyrosine kinase
substrate [3]. Thereafter, several homologs of the STAM/
EAST/Hbp (referred henceforth as STAM) family have been
discovered, and they now comprise a distinct and evolution-
arily conserved protein family with members from yeast to
mammals. Along with the growth of the family, the initial
ideas of the functional roles of its members have diversi¢ed
and become more accurate.
2. Domain organization
The schematic representation of the domain organization of
STAMs is shown in Fig. 1. On the basis of the primary struc-
ture homology, the proteins can be grouped into three sub-
groups. Human STAM 1 is clearly distinct from the second
subgroup with 53% identity with human STAM 2A (same as
Hbp), 64% identity with human STAM 2B, and 60% identity
with chicken EAST. Chicken EAST and mouse Hbp bear 78%
and 86% identity, respectively, with human STAM 2A, thus
putatively representing its homologs. STAM 2B is identical to
STAM 2A, except for the lack of 183 amino acids in its C-
terminus. The third subgroup consists of invertebrate ortho-
logs of the family, bearing an identity of 20^40% to both
vertebrate protein subgroups.
All STAMs have, in their N-terminus, a VHS (Vps27, Hrs
and STAM homology) domain, an evolutionarily conserved
domain of V140 amino acids. It is also found in other pro-
teins which are unrelated to STAMs and are mostly involved
in vesicular tra⁄cking [4]. Interestingly, in all proteins of its
residence, the VHS domain occupies the N-terminus, suggest-
ing the importance of this topology to its function [4]. The
recently staged crystal structures of the VHS domains of Hrs
and Tom1 proteins revealed an eight-K-helix superhelix. Based
on the structural data, the VHS domain is predicted to be
engaged in both inter- and intradomain interactions, and to
function as a low-e⁄ciency membrane-binding domain [5,6].
Recently, a novel ubiquitin-interacting motif (UIM) was
identi¢ed in a wide variety of proteins, most of them involved
in ubiquitination and ubiquitin metabolism [7]. Intriguingly, it
is also present in STAMs (Fig. 1).
In their central portion, STAMs have an SH3 (Src homol-
ogy 3) domain, a well-established protein^protein interaction
domain [8]. In the C-terminal part of vertebrate STAMs (ex-
cept for STAM 2B), there is an ITAM motif, an immuno-
receptor tyrosine-based activation motif which in immunore-
ceptors serve as a docking site for SH2 domain-containing
proteins [9]. ITAM overlaps with a region with a predicted
propensity for coiled-coil arrangement [10].
3. Expression and localization
Northern and immunoblotting analyses showed that STAM
1, STAM 2A and EAST are widely expressed in a variety of
tissues and cell lines, and that there is no change in STAM 1
expression during brain development in mouse [1,2,11,12]. In
chicken embryos, EAST is highly expressed in neuronal cells,
in the endothelium and smooth muscle throughout the tissues,
and in the epithelial cell layer of the gizzard, intestine, lung
and the skin (Lohi and Lehto, submitted). In Drosophila,
STAM is prominent in both embryos and adults, with lower
level of expression in ¢rst-, second-, and third-instar larvae
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and in pupae [13]. Thus, no distinct cell or tissue-speci¢c ex-
pression pattern is to be seen.
Information on the subcellular distribution is available for
STAM 1 and EAST. In primary hippocampal neurons of
mouse brain, STAM 1 is associated with spot-like structures
which are also positive for the synaptic markers GluR1, syn-
apsin-I and SNAP-25 [12]. In subcellular fractionation studies,
STAM 1 was enriched in the synaptosomal and especially in
the synaptic vesicle fraction, suggesting a role in synaptic ma-
chinery [12].
In immuno£uorescence microscopy studies, EAST dis-
played a staining pattern which is, at least partly, dependent
on the ¢xation techniques. It was seen along the cell mem-
branes, associated with the focal adhesion sites, along ¢lamen-
tous actin, and in vesicular structures which costained for
clathrin [2,14]. All in all, it seems, based on the distinct local-
izations of STAM 1 and EAST, that either the members of
the family di¡er also in their basic functional features or that
they share functional features independent of their cellular
localizations.
4. Role in signal transduction
A pivotal role for STAMs in signal transduction was orig-
inally and strongly suggested by the observation that they
become readily tyrosine-phosphorylated upon stimulation
with a variety of cytokines such that STAM 1 was phosphor-
ylated upon stimulation with IL-2, IL-3, IL-4, IL-7, GM-CSF,
EGF and PDGF; STAM 2A/Hbp with IL-2, IL-3, GM-CSF,
EGF, PDGF and HGF; and EAST with EGF and PDGF [1^
3,15]. Attesting to an association with speci¢c pathways, no
phosphorylation of EAST was seen upon treatment with ly-
sophosphatidic acid, phorbol myristic acid or bradykinin [2].
The cytokine signalling pathways were further scrutinized and
STAM 1 and STAM 2A were found to be associated with
Jak2 and Jak3, downstream e¡ectors of IL-2 signalling
[11,16]. This binding is through the ITAM region of STAM
1/2A and is not dependent on ligand stimulation. Similarly,
association between EAST and EGF-receptor was found and
shown to be constitutive and only enhanced by EGF stimu-
lation [2].
The molecular details of the tyrosine-phosphorylation of
STAMs remain to be sorted out. There are, however, interest-
ing di¡erences in STAMs associated with distinct signalling
pathways as to the site and number of the phosphorylatable
tyrosine residues and to their regulation. For instance, phos-
phorylation by Jak1/2/3 of STAM 1/2A is dependent on the
ITAM motif while phosphorylation of EAST/STAM 2A by
EGF is not [2,15,16]. Our own studies also demonstrated that
EAST is a direct substrate of both EGFR and Src kinases
[2,17]. It still remains unresolved what the signi¢cance of the
tyrosine-phosphorylation of STAMs is for downstream signal-
ling and whether kinases other than Jaks, EGFR and Src are
involved.
The original discovery of STAM 1 was based on an as-
sumption that there is a STAT5-independent pathway from
IL-2-receptor via Jak2 and Jak3 to c-myc induction and DNA
synthesis, respectively [1,16]. A speci¢c role of STAM 1 and
STAM 2A in c-myc induction was later demonstrated in
transfection studies which showed it to be dependent on the
presence of the SH3 or ITAM domain [11,15,16]. SH3 dele-
tion mutants of STAM 1 and STAM 2A acted in a dominant
negative manner by suppressing cell growth signalling medi-
ated by IL-2 and GM-CSF. Moreover, their coexpression in-
duced an additive suppressive e¡ect on DNA synthesis [11].
Since both STAM 1 and STAM 2A bind Jak2 and Jak3, this
suggests that they contribute to the cytokine-mediated signal
by comparable and compensatory mechanisms downstream of
Jak2 and Jak3. Similar to SH3 domains, ITAM domains are
known to serve mostly as docking sites of components of
multimolecular assemblies. For instance, various SH2 do-
main-containing proteins, either adapter proteins or kinases,
bind to ITAM(s) of immunoreceptors to further e¡ect phos-
phorylation of the receptor itself or its downstream e¡ectors
[9]. Although not scrutinized in detail, ITAMs in STAM may
serve a similar purpose in anchoring Jak kinases to the vicin-
ity of their appropriate targets.
Based on the role of STAMs in cytokine signalling, it was
to be expected that they are central players in, for example,
lymphocyte development. Therefore, it came as a surprise that
knockout of STAM 1 had little e¡ect on the development in
mouse of hematopoietic cells, including T-, B-, myeloid and
erythroid cells, and on the proliferative responses of bone
marrow cells and splenocytes in response to IL-2 and GM-
CSF [12]. Obviously, this can be due to redundancy such that
STAM 2A compensates for STAM 1. A curious observation
was that the knockout animals showed an apoptotic loss of
CA3 pyramidal neurons. This suggests that derangement of
STAM 1-mediated signalling, while not compromising neural
cell development, leads to a shortened cell survival and apo-
ptosis [12]. Maybe, in these particular cells, in contrast to
lymphocytes for example, STAM 1 is in a signalling pathway
critical to survival and not balanced by compensatory path-
ways.
An interesting link between STAMs and signal transduction
is provided by a recently discovered AMSH (associated mol-
ecule with the SH3 domain of STAM) protein that was found
via a far-western screen. It interacts with the SH3 domain of
STAM 1 and STAM 2A [11,18]. AMSH lies in the signalling
pathway from IL-2 and GM-CSF to c-myc induction and
DNA synthesis, possibly as a component of a multimolecular
complex comprised of cytokine receptors, Jaks, STAM and
AMSH [18]. Quite recently, AMSH was found to be involved
Fig. 1. Schematic representation of the domain structure of STAMs.
The orthologs of STAMs are abbreviated as Dstam for the Droso-
phila melanogaster, Cestam for the C. elegans, Spstam for the
S. pombe, and Scstam for the S. cerevisiae homologs.
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in the bone morphogenetic protein (BMP) signalling [19]. By
binding to and sequestering Smad6, an ‘inhibitory Smad’ and
an antagonist of the BMP^Smad pathway, AMSH seems to
be able to positively regulate BMP-induced responses.
The involvement of AMSH in various, otherwise disparate
signalling pathways, suggests that, by way of binding to it,
STAMs could be part of a network that sets parallel signalling
pathways to balance and orchestrates their potencies and du-
rations. Interestingly, Itoh et al. [19] reported that overexpres-
sion of AMSH in HS-72 cells resulted in an increased Fas-
induced apoptosis. Could it be that the elevated level of apo-
ptosis in CA3 cells in STAM 1 knockouts could be due to
illicit levels of AMSH as a result of missing STAM 1?
Recently, a 72-kDa immunoanalog of STAM 1 was found
in a search for tyrosine-phosphorylated proteins after PDGF
treatment [20]. It was demonstrated to form a high-a⁄nity
complex with Eps15, Crk and Fyn [20], further pointing to
a role of STAMs in signal transduction.
5. Role in endocytic tra⁄cking
Several lines of evidence support a role for STAMs in en-
docytic tra⁄cking. First, EAST is associated with EGF-recep-
tor and Eps15, an EGFR substrate that binds to AP-2 and
other endocytosis-associated proteins such as epsin and syn-
aptojanin [2,21]. Second, STAM 1 and STAM 2A/Hbp are
associated with Hrs, a VHS and FYVE domain-containing
endocytosis-associated hepatocyte growth factor-regulated ty-
rosine kinase substrate (Fig. 2) [3,10,22]. Third, STAMs have
a UIM motif which is found also in some proteins involved in
endocytic receptor down-regulation. Fourth, the domain
structure of STAMs (especially the presence of the VHS do-
main), and the subcellular localization studies (see above) are
suggestive of STAMs participating in endosomal tra⁄cking.
The role of Eps15 in endocytosis was established by experi-
ments showing that perturbation of Eps15 function inhibits
receptor-mediated endocytosis of EGF and transferrin [23].
EAST associates with Eps15 [2]. The signi¢cance of this in-
teraction is, however, not known. It is independent of EGFR
activation and is not mediated by the EAST’s NPF-motif, a
site responsible for Eps15 interactions with many other li-
gands [2,21]. On a more general note, there is an NPF-motif
to be found in the N-termini of most STAMs. Thusfar, how-
ever, no binding partners have been found and their function-
al role remains to be studied.
The role of Hrs in endosomal tra⁄cking is implicated by its
presence in early endosomes and multivesicular bodies, and
that it recruits clathrin to early endosomes [22,24]. Moreover,
Hrs-2 (identical to Hrs) interacts with Eps15, and transiently
overexpressed Hrs-2 or its Eps15-binding region inhibits re-
ceptor-mediated endocytosis [25]. Recently, Chin et al. [26]
demonstrated a direct interaction between Hrs and sorting
nexin 1 (SNX1), a protein that participates in lysosomal traf-
¢cking of EGFR. Overexpression of Hrs or its SNX1-binding
domain, which overlaps with the site mediating binding to
STAMs, inhibits ligand-induced degradation of EGFR. This
together with the observation that a complex formed by
SNX1 and Hrs excludes EGFR, suggest a role for STAMs
in the regulation of the receptor degradation: displacement of
SNX1 from a complex with Hrs by STAM could make SNX1
available for binding to EGFR and recruit it for degradation.
Based on the experimental evidence by Chin et al [26], it can
also be predicted that STAMs would act in a later, lysosome-
targeting stage of endocytosis but not have a role in the early
stages of endocytosis. On the other hand, association of
EAST with Eps15, which operates in the formation of the
coated pits, would suggest some function for STAMs also at
this early stage of endocytosis.
More direct evidence for the role of STAMs in Hrs-medi-
ated endocytotic events is provided by studies showing that
Hrs and STAM 1/Hbp interact with each other through the
coiled-coil sequence(s) present in both proteins [3,10]. Re-
cently, in Saccharomyces cerevisiae, the Hrs homolog
Vps27p and the STAM homolog were shown to interact
[27]. In STAMs, the coiled-coil region (aa 350^377 in
STAM 1) partially overlaps the ITAM domain (aa 370^387
in STAM 1), and it interacts with the second coiled-coil (CC2)
region of Hrs [10,22]. Since both the FYVE and CC2 domains
of Hrs are required for its early endosome localization [22], it
is tempting to speculate that STAMs could, by competing for
the endosome binding, interfere with the Hrs targeting.
Takata et al. [3] demonstrated that a transient overexpres-
sion of STAM 2A/Hbp mutants lacking either the SH3 or the
Hrs-binding coiled-coil domains inhibited the intracellular
degradation of PDGF and its receptor, corroborating the
idea that STAM is a central player in Hrs-mediated endocytic
events.
The role of STAMs in IL-2 signalling is generally associated
only with the signalling cascade from the receptor to the
downstream pathway. A recent observation that IL-2 recep-
tors utilize a clathrin-independent endocytosis pathway that is
coupled to detergent-resistant membrane domains makes it an
intriguing possibility that STAMs would be involved also in
this novel endocytic machinery [28].
The role of STAMs may not be restricted to endocytosis
only but may be more widely applicable to vesicular tra⁄ck-
ing. This is based on the studies of Murai et al. [29] with the
mutant proteins lacking either the SH3 or the Hrs-binding
coiled-coil domains. Their overexpression in mast cells inhib-
ited the immunoglobulin E (IgE) receptor-triggered degranu-
lation of secretory granules. These results suggest that STAMsFig. 2. STAMs and their binding partners.
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play a regulatory role in the IgE receptor-triggered exocytosis.
In regard to its role also in endocytosis, it can be envisioned
that STAMs could have an important regulatory function in
coordinating, both spatially and temporally, the closely linked
endo- and exocytic vesicle events.
The presence of the UIM motif, a consensus binding site for
proteins carrying ubiquitin, in STAMs suggests its involve-
ment in ubiquitin-mediated endocytosis. In this regard, it is
interesting that EGFR and Eps15, both interacting with
EAST, are ubiquitinated upon EGF binding [30]. That
STAMs could be components of a larger complex of a ubiq-
uitin machinery is suggested by a study of Kato et al. [31],
showing that the deubiquitinating enzyme UBPY binds to the
SH3 domain of STAM 2A/Hbp (Fig. 2). A speci¢c sequence,
Px(V/I)(D/N)RxxKP, which is distinct from the consensus
SH3-binding PxxP motif, was identi¢ed as the SH3-binding
motif in UBPY. A peculiar feature which further points to
¢nely tuned speci¢c interactions and possibly to a speci¢c
class of multiprotein complex-forming molecules, is that the
proteins containing similar SH3-binding motifs are mostly
members of multidomain linker proteins such as SLP-76
and Gab1 [31]. Intriguingly, this same SH3-binding motif is
also present in AMSH, in which it mediates the interaction
with the SH3 domain of STAM [31].
Ubiquitination of growth factor receptors regulate their in-
tracellular degradation. SH3 deletion in STAM 2A/Hbp leads
to an inhibition of receptor-mediated endo- and exocytosis.
Thus, UBPY may play a positive regulatory role in receptor
degradation by interaction with the SH3 domain of STAM
2A/Hbp.
6. Other functional features
It is well-established that the endocytotic machinery is
closely linked with the dynamics and integrity of the actin
cytoskeleton [32]. Of a special relevance to the present discus-
sion is the observation that directly connects Pan1p, a puta-
tive yeast ortholog of Eps15, to actin polymerization [33]. Our
own studies showed a direct interaction between the N-termi-
nus of EAST, containing the VHS and UIM domains, and
actin [14]. This is suggestive of STAMs functioning also as
integrators between endocytosis and cytoskeletal events.
7. Concluding remarks
STAMs are closely involved, ¢rst, in the regulation of the
cytokine-mediated signal transduction, and second, in the reg-
ulation of the receptor-mediated endocytosis. Accumulating
evidence suggests that they probably act, in combination
with positive and negative interactors, as regulators and inte-
grators of parallel signalling pathways. STAMs may also have
a role in regulating and driving later endocytotic events, es-
pecially those associated with the formation of early endo-
somes and their subsequent fate, in some exocytic events,
and in a pathway regulating cell survival in neural cells.
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